AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
AstraZeneca
Study ID
NCT06137118
Phase
PHASE1/PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • B-cell Acute Lymphoblastic Leukemia (B-ALL)

Eligibility Criteria

Sex
ALL
Age
12 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • AZD0486 — DRUG
    Investigational Product administered via intravenous infusion.

Study Details

This is a Phase 1/2, global multicentre, open-label, single-arm, dose escalation and dose optimisation study of AZD0486 to evaluate the safety, tolerability, and efficacy of AZD0486 monotherapy in participants with R/R B ALL who have received ≥ 2 prior lines of therapies. The study will consist of 3 parts. Part A monotherapy dose escalation. Part B dose optimisation. Part C Dose expansion at the recommended phase 2 dose (RP2D)

Key Dates

Start date
Dec 29, 2023
Status verified
May 2026
Primary completion
Nov 13, 2026
Completion
Jun 29, 2027

Study Design

Enrollment
236 participants (estimated)
Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT

Arms

  • Experimental: Part A: AZD0486 Dose Escalation
    Ascending dose level cohorts of AZD0486 in B-ALL participants aged 12 years and above.
  • Experimental: Part B: Dose Optimization
    Up to 2 cohorts will be evaluated prior declared safe-doses and schedules in order to determine the recommended phase 2 dose (RP2D). Participants, aged 12 years and above, will receive AZD0486 IV infusions and will be randomized in a 1:1 ratio.
  • Experimental: Part C: Dose Expansion
    Part C will consist of 1 cohort of participants aged 12 years and above, treated with the optimal dose selected in Part B and receive IV AZD0486 monotherapy.

Primary Outcome Measure

Part A: Frequency of DLTs [ Time Frame: Up to 28 days ]

Central Contacts

Locations (12)

FacilityCityStateZIPSite coordinators
Research SiteBirminghamAlabama35233-
Research SiteDuarteCalifornia91010-
Research SiteLos AngelesCalifornia90048-
Research SitePalo AltoCalifornia94304-
Research SiteTampaFlorida33612-
Research SiteAtlantaGeorgia30322-
Research SiteChicagoIllinois60637-
Research SiteNew YorkNew York10016-
Research SiteHoustonTexas77030-
Research SiteRichmondVirginia23298-
Research SiteSeattleWashington98109-
Research SiteMilwaukeeWisconsin53226-

Find similar trials in Birmingham, AL

By research site
Research Site· Birmingham, ALResearch Site· Duarte, CAResearch Site· Los Angeles, CAResearch Site· Palo Alto, CAResearch Site· Tampa, FLResearch Site· Atlanta, GA

Related Studies